Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Indoco Remedies has informed that it enclosed the transcript of Earnings Conference Call held on 07th May, 2026 at 03:30 pm (IST) in respect of Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026. The Earnings Conference Call concluded at 04:23 pm (IST) on 07th May, 2026.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1779.35 |
| Dr. Reddys Lab | 1267.05 |
| Cipla | 1397.75 |
| Zydus Lifesciences | 1085.45 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: